Jean Jacques Bienaime is of Immunome Inc.. Currently has a direct ownership of 16,615 shares of IMNM, which is worth approximately $182,765. The most recent transaction as insider was on Aug 16, 2024, when has been sold 7,000 shares (Common Stock) at a price of $13.94 per share, resulting in proceeds of $97,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.6K
0% 3M change
n/a 12M change
Total Value Held $182,765

JEAN JACQUES BIENAIME Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
BUY
Open market or private purchase
$97,580 $13.94 p/Share
7,000 Added 29.64%
16,615 Common Stock
May 21 2024
BUY
Open market or private purchase
$27,140 $13.57 p/Share
2,000 Added 17.22%
9,615 Common Stock

Also insider at

INCY
INCYTE CORP Healthcare
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
KROS
Keros Therapeutics, Inc. Healthcare
JJB

Jean Jacques Bienaime

San Rafael, CA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Track Activities on IMNM